Stay updated on KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial
Sign up to get notified when there's something new on the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page.

Latest updates to the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page
- CheckyesterdayChange DetectedThe study record for KBL693 is now displayed, including its completed status, study design, eligibility criteria, outcomes, and Australian location.SummaryDifference45%

- Check8 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide NIH notice announces updates and FAQs about a transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial record remains unavailable behind a 403 error.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error rather than a study record.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the previous study content. This indicates the page is currently inaccessible.SummaryDifference18%

Stay in the know with updates to KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KBL693 Multiple Ascending Dose in Healthy Participants Clinical Trial page.